Dopamine agonist and dopamine precursor combination

This page covers all Dopamine agonist and dopamine precursor combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Dopamine D2/D3 receptors (ropinirole); dopamine synthesis pathway (L-dopa).

Targets

Dopamine D2/D3 receptors (ropinirole); dopamine synthesis pathway (L-dopa)

Marketed (1)

• ropinirole/L-dopa · GlaxoSmithKline · Neurology
  Ropinirole is a dopamine D2/D3 receptor agonist that mimics dopamine signaling, while L-dopa is a dopamine precursor that increases dopamine levels in the brain.

Patent intelligence

• dopamine agonist and dopamine precursor combination patent landscape — aggregated cliff calendar, attackable patents, originator estates